(Q54633763)

1 June 2018

title

Therapy of Deep-Seated Fungal Infections with 5-Fluorocytosine (English)

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

13 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

13 February 2023

1

F. C. Firkin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4616675

13 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4616675

13 February 2023

publication date

1 October 1974

1 reference

1 June 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1445-5994.1974.tb03218.x

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1445-5994.1974.tb03218.x/fullpdf

13 February 2023

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

Australian and New Zealand journal of medicine

13 February 2023

published in

1 reference

1 June 2018

volume

4

1 reference

1 June 2018

issue

5

1 reference

1 June 2018

page(s)

462-467

1 reference

1 June 2018

5-fluorocytosine in the treatment of cryptococcal and candida mycoses.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03218.X

Amphotericin B in cryptococcal meningitis. Long-term results of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03218.X

21 January 2018

5-Fluorocytosine Therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03218.X

Variables influencing susceptibility testing of Cryptococcus neoformans to 5-fluorocytosine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1974.TB03218.X

5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

5-Fluorocytosine in human cryptococcosis

13 February 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

Candida Endocarditis Treated with 5-Fluorocytosine

13 February 2023

4

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

Urinary candidiasis after renal transplantation

13 February 2023

8

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

Two Cases of Cryptococcal Meningitis, one Treated with 5-Fluorocytosine

13 February 2023

9

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

The metabolism of 5-fluorocytosine-214C and of cytosine-14C in the rat and the disposition of 5-fluorocytosine-214C in man

13 February 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

The Kinetics of 5-Fluorocytosine Elimination in Man

13 February 2023

14

1 reference

https://api.crossref.org/works/10.1111/J.1445-5994.1974.TB03218.X

13 February 2023

Identifiers

1 reference

1 June 2018

1 reference

1 June 2018